Long non-coding RNA expression data has been increasingly used in finding diagnostic and prognostic biomarkers in cancer studies. Existing differential analysis tools for RNA sequencing does not effectively accommodate low abundant genes, as commonly observed in lncRNA. We propose a novel and robust statistical method lncDIFF to detect differential expressed (DE) genes without assuming the true density on normalized counts.
INTRODUCTION
Long noncoding RNAs (lncRNAs) are transcripts longer than 200 nucleotides with no or limited proteincoding capability. It is estimated that, in the human genome, there are at least four times more lncRNA genes than protein-coding genes [1] . Currently, there are more than 14,000 human lncRNAs annotated in GENCODE (https://www.gencodegenes.org/). Overall, lncRNA genes have fewer exons, lower abundance and are under selective constraints compared to protein-coding genes. LncRNAs are involved in diverse regulatory mechanisms and in some critical pathways. For example, they can act as scaffolds to create higher-order protein complexes, as decoys to bind sequester transcription factors, and as guides of protein-DNA interactions [2] [3] [4] . Emerging evidence suggests that lncRNA serve as essential regulators in cancer cell migration and invasion, as well as in other cancerous phenotypes [5, 6] .
Therefore, lncRNAs are becoming attractive potential therapeutic targets and a new class of biomarkers for the cancer prognosis and diagnosis. For example, the lncRNA PCA3 (prostate cancer antigen 3) is a FDA-approved biomarker for prostate cancer prediction. The overexpression of lncRNA HOTAIR in breast cancer patients is reported to be associated with patient survival and risk of metastasis [7] . Another important lncRNA ANRIL (CDKN2-AS1) is one of the most frequently alerted genes in human cancers and has been reported to increase cancer risks in diverse cancers.
Although a large number of lncRNAs have been identified, only a very small proportion of them have been characterized for cellular and molecular functions. Similar to protein-coding genes, the biomarker discovery of lncRNAs can start from a genome-wide differential expression (DE) analysis. One advantage of lncRNAs research in cancer is that we can leverage the large collection of previously published RNA-seq data and perform secondary analyses. Unlike the miRNAs counterparts, the expression of a large number of lncRNAs can be detected by standard RNA-seq with sufficient sequencing depth. Through downloading RNA-seq BAM files and recalling using GENCODE genomic coordinates, more than 8,000 human tumor samples across all major cancer types in The Cancer Genome Atlas (TCGA) and other published studies have been re-analyzed for the lncRNAs expression profile [8, 9] . There is a limited number of non-tumor samples sequenced for RNA-seq in TCGA. If necessary, the database such as the GTEx (http://gtexportal.org) can serve as additional tissue-specific controls, which provides over 9,600 RNA-seq samples across 51 tissues. lncRNAs expression data have several features that pose significant challenges for the data analysis, including low abundance, large number of genes, and rough annotations. To ensure detection reliability, a common practice is to filter out lncRNA genes with low average Reads Per Kilobase per Million mapped reads (RPKM), e.g. <0.3. We recommend using the two-step filter proposed in [9] : in the first step eliminates genes with 50th-percentile RPKM =0, and in the second step only keep genes whose 90th-percentile RPKM <0.1. About two-thirds of lncRNAs are excluded after this filtering procedure.
Interestingly, excess zeros or low expression values are still observed in the downsized dataset. It is well known that excess zero read counts in RNAseq data can distort model estimation and reduce power in differential expression analysis. The popular R packages DESeq2 and edgeR assume a negative binomial (i.e. over-dispersed Poisson) distribution for the count data. Methods based on zero-inflated negative binomial (ZINB) and zero-inflated GLM have been proposed to explicitly address the issue of excess zeros in RNA-seq data [10] . These methods have been recently applied to single-cell RNA-seq (scRNA-seq) data, which has high dropout rates. Since the difference in gene expression variance is biologically interesting, multiple methods have been developed to incorporate the testing of variance in the differential model. However, for biomarkers in clinical settings, genes with pronounced group contrast in mean expression level usually have more translation value. Gene wise expression variability can generate from different sources and varies widely from study to study, especially with different normalization methods. Hence, we focus on the group comparison of mean gene expression level regardless of variability in this study.
In a large-scale secondary analysis of expression data such as in lncRNA studies, only normalized data (such as RSEM or RPKM) are available [11, 12] . Certain packages such as DESeq2, however, cannot be applied because they do not accept normalized expression and zero as input. In this case, a common practice is to round continuous expression values into integers and shift it to be nonzero.
Another commonly-adopted approach is using ! ( + 1) transformed normalized data in R package like limma [13] , i.e., assuming a log-transformed Gaussian distribution as in microarray intensity levels.
The core function in limma, which basically runs a moderated t-test after an empirical Bayes correction, is more generic and more suitable for the differential expression of processed lncRNA expression data. In a very recent study, a total of 25 popular methods for testing differential expression genes were comprehensively evaluated with special emphasis on low-abundance mRNAs and lncRNAs [14] . It was observed that linear modeling with empirical Bayes moderation (implemented in limma with variance stabilizing transformation [15] , voom [16] or trend), and a non-parametric method based on Wilcoxon rank sum statistic (implemented in SAMSeq) showed overall good balance of false discovery rate (FDR) and reasonable detection sensitivity. However, none of the methods compared can outperform all other tools and all tools exhibited substandard performance for lncRNAs in terms of differential testing, often with higher FDR and true positive rate (TPR) than for mRNAs. This study also concluded that accurate differential expression inference of lncRNAs requires more samples than that of mRNAs. Even methods like limma can exhibit an excess of false discoveries under specific scenarios, making these methods unreliable in practical applications.
In this paper, we present the lncDIFF, an efficient and reliable toolset based on a zero-inflated exponential quasi-likelihood strategy without the need to fully specify a parametric model. The quasilikelihood model provides unbiased and efficient estimators even under erroneous assumptions about density. It thus provides a simple and versatile approach to model gene expression data without making strong distributional assumptions about the underlying variation, but still being compatible with existing RNA-Seq quantification and normalization tools. The flexibility in allowing for the estimation of calibration and variance parameters is especially important for lncRNAs differential analysis. The lncDIFF is thus able to integrate desirable features from the aforementioned two top-performing methods (limma and SAMSeq [14] ) for lncRNA differential analysis. The lncDIFF is compared with existing tools using an extensive simulation study and real data analysis on TCGA head and neck squamous cell carcinomas (HNSC). Results suggest that lncDIFF is powerful and robust in a variety of scenarios and identifies DE lncRNA genes of low expression with more accuracy.
METHOD

RNA-Seq Counts Distribution Based Variation
In RNA-Seq gene expression analysis, the type of RNAs and the selected alignment, quantification and normalization tools usually have substantial impact on the distribution pattern of transcript abundance as discussed in [17] , especially on the level of gene expression dispersion, i.e. the mean-variance relation. Most of the existing RNA-Seq tools, such as DESeq [18] , edgeR [19] , and baySeq [20] estimate gene-wise counts dispersion to perform raw counts normalization or differential expression analysis. However, this technique may not be suitable for low-abundance mRNA or lncRNA.
The analysis tools such as limma [13, 21] with data transformation become superior for lncRNA instead [14] . In other words, the underlying mean-variance relation distinguishes different types of RNA-Seq counts and determines the tools for downstream analysis.
Let !" represent RNA-Seq read counts mapped to gene in sample , = 1, … , , = 1, … , .
The existing analysis on RNA-Seq data usually assumes Negative Binomial (NB) or the Log Normal (LN) distribution for raw or normalized counts [14, 16] , with mean-variance relation summarized as a quadratic form for NB and = exp ! − 1 for LN [18] . The parameters ! , are the mean and dispersion of NB, and is the log standard deviation of LN, not affected by the log mean.
We use the lncRNA and mRNA data in the TCGA HNSC study to investigate the variation patterns for different types of sequencing counts. If the quantified RNA-Seq reads follow a NB distribution, the gene-wise variation or CV changes inversely with mean expression level, as revealed by the violin box plots for mRNA normalized counts in Figure 1 . In contrast, the CV level for lncRNA normalized counts in the same study presented by Figure 1 does not change along with gene-wise mean at 20 th -50 th percentiles, similar to the LN distribution in which CV is independent of (log) mean.
For mRNA read counts, NB density is a valid assumption and provides robust estimate for the mean expression, dispersion and DE analysis. However, the scale and distribution of lncRNA counts varies across genes, some of which are extremely low and similar to LN, or have a mixture distribution of NB and LN. The differential analysis for a large number of lncRNA genes with mean expression ranging from less than 1 to over 100 can be severely biased, if one uses NB model to account for dispersion across all genes, or transformation such as log2 [22] , voom [16] and variance stabilizing transformation (VST) [15] to remove the skewness for all genes. In the light of fewer statistical assumptions and parameters, it is worth to investigate the plausibility of utilizing Exponential density in RNA-Seq analysis, for which the quadratic mean-variance relation is CV = 1.
Exponential Quasi-Likelihood
In this study, we only consider the normalized lncRNA expression data, i.e. Reads Per Kilobase per Million mapped reads (RPKM) [23] or Fragments Per Kilobase per Million mapped reads (FPKM), as the aim is to improve hypothesis testing of treatment or biological group effect on lncRNA expression regardless of the latent variation pattern. The common normalization methods, such as UQ, TMM [24, 25] are also compatible with lncDIFF, but not assessed in the simulation study and real data analysis, due to limited publically available lncRNA raw counts. We will demonstrate that the choice of normalization method does not affect the validity and accuracy of parameter estimation and DE analysis results in lncDIFF. See the last subsection of Method.
Let !" be the lncRNA RPKM for gene in sample , belonging to phenotype or treatment group , = 1, … , . The generalized linear model (GLM) for !" with the Exponential family is
!" and !" are design matrix elements and unknown coefficients for groups, !" and ! are the covariates and corresponding coefficients. Since !" has been normalized for library size, this model does not include the RNA sequencing normalization factor, although it is a common parameter in existing tools based on NB assumption [18, 19, 26, 27] .
In the absence of zero expression, lncDIFF uses the Exponential GLM to lncRNA RPKM DE analysis regardless of the true density of !" as a quasi-likelihood approach, which uses a distribution-free statistics to estimate group-wise mean RPKM, similar to the pseudo likelihood (PL) and quasi likelihood (QL) for dispersion estimate in [27] . Let ! = ( !!,…, !" ) and = ( !,…, ! ), for gene with negligible zero occurrence (<1%), the GLM likelihood based on the exponential density
! !" with identity or log link function is
Logarithmic link:
The exponential quasi likelihood estimate for mean RPKM in lncDIFF is the maximizer of ! , , that is ( ! , ) = ! , . This estimate does not require prior knowledge about the statistical distribution of RPKM values, and accommodates the genes with a wide range of expression, i.e. having both extremely low (RPKM<1) and regular (RPKM>10) abundance in a large proportion of samples. The commonly adopted statistical assumptions like Poisson, NB or LN densities about RNA-Seq counts are still allowed in lncDIFF. However, the specified density does not affect the estimation of mean RPKM ( ! ) and the corresponding DE analysis results, as illustrated in the Supplementary Methods and simulation study.
Zero-Inflated Exponential Quasi Likelihood
In lncRNA expression data, it is common to observe zero value for a gene in a non-negligible proportion (i.e., at least 1%) of samples. The excess zeroes in lncRNA RPKM cannot be addressed by integer models like Poisson and Negative Binomial (or Gamma-Poisson), since RPKM for most lncRNA genes are non-integer and fall in the range of (0, 2). Rounding decimals to integers and then applying Poisson or NB density [22, 28] or using data transformation, e.g. log2, voom, or VST [15, 16, 22] with limma [13, 21] may lead to errors in DE analysis. Therefore, we propose the zero-inflated quasi likelihood for the GLM of !" to account for the inflation of zeros in lncRNA expression.
In order to incorporate the zero-inflated pattern, we first re-specify the RPKM for gene in sample by a multiplicative error model [29] [30] [31] with random error !" , that is
The random errors !" also have the occurrence of excess zeros with a prior probability mass !" = 0 = 1 − π, !" > 0 = π, and a continuous density at positive value with ( !" | !" > 0) = γ, similar to [30, 32, 33] . If the positive RPKM !" | !" > 0 follows the Exponential distribution (so does !" !" > 0 , then the density functions for !" including zero occurrence is
Equation (4) is derived in the Supplementary Methods. See supplementary data files. Similar to the aforementioned Exponential quasi-likelihood for GLM, lncDIFF applies the zero-inflated density in equation (5) to GLM as a quasi-likelihood approach to perform DE analysis of zero-inflated lncRNA expression. The corresponding quasi-likelihood function is * π, ! , =
! * π, ! , is defined according to the selected link function as Identity link:
The zero-inflated quasi-maximum likelihood (ZI-QML) estimate for group-wise mean RPKM is the maximizer of * π, ! , in equation (6), that is
It is worthwhile to note that the likelihood function * π, ! , in equation (5) reduces to equations (1) and (2) if the proportion of zero expression is negligible, i.e. no more than 1%.
Likelihood Ratio Test
For differential analysis in lncDIFF, we apply the Likelihood Ratio Test (LRT) to the zero-inflated exponential likelihood function * π, ! , to test hypothesis: ! : ! = !"## vs ! : ! = !"## , where !"## is the design matrix coefficients with some equal to zero and !"## is the coefficients without zero. The test statistic of LRT is = −2 * !"## + 2 * !"## with !"## and !"## being the design matrix coefficients for null and alternative models. Let !"## and !"## be the number of distinct coefficients in !"## and !"## .
Test statistic asymptotically follows ! distribution with degrees of freedom !"## − !"## . The p-values from LRT are adjusted for multiple testing using the procedure of Benjamin and Hochberg false discovery rate [34] . The choice of link function does not affect the power of LRT, as illustrated by simulation study.
We also provide empirical distribution of LRT statistics to compute the p-values for DE analysis, similar to [28] . The empirical distribution of statistics per gene can be generated by randomly shuffling the samples into K groups for P times and then calculate the LRT statistics for each permutation, that is ! , … , ! . Let the test statistics for the true groups be ! , then the empirical p-value is
can be adjusted by Benjamin and Hochberg procedure. We implemented the LRT for lncRNA DE analysis based on ZI-QML with observed and empirical p-values.
lncDIFF on Other Normalization Methods
lncDIFF adopts the estimator (π, ! , ) !"!!"# in equation (6) to estimate the mean gene expression level, based on a likelihood function that captures zero-inflation pattern without assuming the true density of non-zero RPKM. We can theoretically prove that this estimate is asymptotically unbiased, i.e., (π, ! , ) !"!!"# converges to the true value of (π, ! , ) as sample size increases.
According to [35, 36] , (π, ! , ) !"!!"# is asymptotically unbiased as long as * π, ! , converges to [ ! * π, ! , ] and [ ! * π, ! , ] is uniquely maximized at the true value, i.e. π ! , !! , ! . Suppose
. By law of large numbers, it is not hard to show that * π, ! , In order to illustrate normalization method having no impact on lncDIFF performance, we simply applied lncDIFF DE analysis to three different types of normalized counts (i.e., FPKM, TMM and UQ) of low abundance mRNA in TCGA HNSC tumor-normal samples (N=546). The low abundance genes are selected with mean FPKM in the range of (0.3, 2) and no more than 20% zero expression, similar to the majority of lncRNA genes. The Pearson correlation of log10 adjusted p-values between the three normalization methods are FPKM vs TMM 0.82, FPKM vs UQ 0.92, TMM vs UQ 0.96, implying similar DE analysis results. Therefore, we only use RPKM of lncRNA in TCGA HNSC study to illustrate the application and performance of lncDIFF in Results.
In addition to TMM and UQ, the distribution-free parameter estimation and LRT in lncDIFF are also compatible with model-based RNA-Seq quantification and normalization tools, such as RSEM [37] , baySeq [20] , and QuasiSeq [38] . Hence, the lncDIFF DE analysis can be incorporated into existing RNA-Seq quantification and normalization pipeline, regardless of the models employed in the preprocessing tools.
RESULTS
Simulation study to assess lncDIFF performance
We conducted a comprehensive simulation study to demonstrate the performance of ZI-QML with observed p-value of LRT and compare to existing common tools DESeq2, edgeR and limma (with log transformation). We rounded decimals to integers as input for DESeq2 and selected the quasi-likelihood estimation method in edgeR. The testing methods for DE genes were LRT in DESeq2 and edgeR, F-test in limma. We considered NB and LN as true densities for data sampling, and used the gene-wise estimate for dispersion or log variance from a real lncRNA RPKM dataset to determine the values of In the simulation study, we only considered two-group comparison to illustrate the contrast between different methods. RPKM of the first group is randomly-generated by the specified density function and the baseline parameter, while the second group has the mean parameter of the baseline times a shift, i.e., the tumor/normal fold change in TCGA HNSC data. We manually set the shift between two simulated groups at 1 if the absolute log2 fold change (LFC) for the corresponding gene is less than 0.5. Simulated genes with between-groups shift at 1 are the null genes and the remaining are DE genes.
For each simulated scenario, we generate 100 replicates to assess the performance of different methods by the mean of Type I error, false discovery rate (FDR), true positive rate (TPR), and area under the curve (AUC) of receiver operating characteristics (ROC) with FDR threshold 0.05.
We order the scenarios by the level of variance (with 1-4 representing the smallest to the largest and determined by dispersion or log variance), proportion of nonzero expression, and sample size to investigate the impact of parameters on performance metrics. Figure 2 and Supplementary Figures S1-S3 present the AUC, FDR, TPR and Type I error (or false positive rate) of all scenarios, illustrating that ZI-QML outperforms the other methods, especially for scenarios with LN density. AUC for all methods in Figure 2 decrease as the gene-wise variation increases, and it also shows that ZI-QML's performance is close to the optimal method (DESeq2) for NB density. 
Application of lncDIFF to TCGA HNSC Data
We first employed the same methods to perform DE analysis on the TCGA HNSC lncRNA data for matched tumor and normal samples. The Venn diagram in Figure 3 (A) shows the overlap and difference of the DE genes identified by four methods. In real data analysis, the proportion of genes with absolute log2 fold change >0.5 and identified as DE is an alternative metric for the true positive rate, while the false positive rate (FPR) can be approximated by the proportion of genes with absolute LFC less than 0.5, 1, 1.5 but identified as DE. The significance threshold for tumor vs normal is set at FDR<0.05. We listed the alternative TPR and FPR in Figure 3 (B) , and presented the contrast between lncDIFF and the other methods by boxplots in Figure 3 (C)-(E), with each panel showing the tumor vs normal group effect on the lncDIFF positive genes identified as negative by other methods. We only include the genes with upregulation for normal tissues and LFC>0.5 in the boxplots. The results in Figure 3 (B) confirms that lncDIFF provides ideal power or alternative TPR (75%) in DE analysis for LFC<0.5, with approximated FPR below 5%. The other methods either have TPR no more than 30% or generates false positives with an approximate probability 44%. The boxplots in Figure 3 (C)-(E) reveal that the group contrast on DE genes identified only by lncDIFF is larger than that identified only by the other methods. This also implies that lncDIFF is less likely to 'miss' the DE genes with large group contrast.
We also applied the same analysis to the unpaired tumor (N=426) vs normal (N=40) samples in 4 . For the same set of HNSC tumor samples, we also used the mRNA RSEM normalized counts to select 20 mRNA genes highly correlated with the 11 tumor-normal DE lncRNA genes by Spearman correlation, listed in the Supplementary Table 1 .
Secondly, we used 72 TCGA HNSC tumor samples with valid Human Papillomavirus (HPV) status (i.e. positive vs negative) to compare DE analysis results by different methods. The FDR threshold is set at <0.1 for this analysis, since the contrast between HPV positive and negative is less pronounced compared to tumor vs normal. The Venn diagram and table in Supplementary Figure S4 (A)-(B) show the overlap of DE genes between different methods along with the approximate power and FPR. lncDIFF still provides more power with FPR controlled at 0.02, while the other methods have DE analysis power close to either zero or FPR. Supplementary Figure S4 (C) are the PCA plots generated by the top 200 significant genes in terms of the FDR of each method. Based on the distance between clusters, lncDIFF top significant genes differentiate the HPV status better than those identified by the other methods do.
DISCUSSION
lncDIFF is an efficient and powerful differential analysis tool for lncRNA RPKM or FPKM. The distribution of lncRNA RPKM is different from that of mRNA, as some genes in lncRNA may have low or even zero expression for a subset of samples, but also have normal expression for the remaining samples. Existing RNA sequencing analysis tools based on a unique density assumption ignore such characteristic and does not take excess of zeros into account. For example, DESeq2 does not allow zero counts and decimals as input data; hence, RPKM must be rounded and transformed to nonzero integers, which reduces the variation of low abundance genes across samples. Although edgeR handles noninteger RNA-Seq expression data and allows zero values, the computation for group effect depends on the estimate of gene-wise dispersion, which can be severely biased for a gene having both normal and low expression occurrence.
The Exponential likelihood function used in lncDIFF is not derived from the true density of lncRNA The distribution of p-values from lncDIFF is also investigated and compared with the other methods in TCGA HNSC tumor vs normal analysis, using simulated p-values from sample permutation.
We randomly selected three genes with different RPKM density patterns to generate the null p-values and then visualized the p-values distribution via QQ plots in Figure 5 . Figure 5 FDR's is around 0.9. In future study, we will extend the lncDIFF to account for technical excess zeros from biological zeros [10] , as well as apply it to lncRNA counts normalized by other methods, such as UQ and TMM.
CONCLUSION
lncDIFF is a novel method utilizing GLM with a distribution free estimator and LRT in differential analysis of lncRNA normalized counts. This is an efficient DE analysis method, being compatible with various RNA-Seq quantification and normalization tools. 
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